Skip to content

Trending News

What Just Happened
4 years agoOptimizeRx Announces Agreement with a Top Pharmaceutical Manufacturer to Use its Evidence-Based Physician Engagement to Solve Lapse in Medical Coverage Barrier for Patients – Stockhouse 4 years agoOM1 Launches Multiple Sclerosis Registry with More than 20000 Patients Prospectively Followed with Deep Clinical Data – Markets Insider 4 years agoReal-World Evidence And Its Use In Advertising Of Medicinal Products In The EU And US – Media, Telecoms, IT, Entertainment – Worldwide – Mondaq News Alerts 4 years agoNational Evaluation System for health Technology Coordinating Center Adds Clinical Laboratory and Patient Engagement Expertise to Governing Committee – Business Wire 4 years agoAbnormal temperatures linked to climate change cause over 740,000 deaths annually in India
Tuesday, May 13, 2025
Primary Menu
  • Categories
    • Real World Research (RWR)
    • RWD Sources
    • Movers and Shakers
    • RWE – Real World Evidence
    • Health Tech
    • Medical Devices
    • RWR & COVID 19
    • Regulatory
    • Oncology
    • Mental Health
    • Schrödinger’s Donkey
    • Decentralised Trials
    • Recently Released
  • Editorials
  • RWR
  • Newsfeed
  • FAQ
  • ABOUT
    • About RWR News
    • About the Authors
    • RWR News Editorial Policy
  • RESOURCES
    • Phoenix RWR Consulting
    • RedBird Reg Intel Tools
    • RWR Study Master File

Tag: Life sciences

  • Home
  • Life sciences
Category:
  • Decentralised Trials
  • Movers and Shakers
  • Recently Released

Goldman Sachs backs clinical trial services in the cloud with $230M equity play amid decentralized trial craze

Goldman Sachs invest $230M in CRO on the back of the decentralised trials craze CONTEXT:  Goldman Sachs joins the decentralised trial Gold rush to invest in the contract clinical research Continue Reading

Posted On : June 30, 2021 Published By : Ken Ashman
Category:
  • Real World Research (RWR)
  • Recently Released
  • RWE - Real World Evidence
  • RWR & COVID 19

Real-world study of vaccine efficacy- Indian Council of Medical Research

The Indian Council of Medical Research (ICMR) launches national Real-World study to assess COVID vaccine. CONTEXT:  A report from the Times of India on the newly launched Indian Council of Continue Reading

Posted On : June 28, 2021 Published By : Ken Ashman
Category:
  • Real World Research (RWR)
  • Recently Released
  • RWE - Real World Evidence
  • RWR & COVID 19

Coronavirus: two AstraZeneca vaccine doses could be up to 90 per cent effective, UK real-world data suggests | South China Morning Post

CONTEXT:  High level report from Public Health England on preliminary findings from RWR on the Astra-Zeneca coronavirus vaccine shows two doses to be up to 90% effective | UJK only Continue Reading

Posted On : June 8, 2021 Published By : Ken Ashman
Category:
  • Real World Research (RWR)
  • Recently Released
  • RWE - Real World Evidence

Real-World Data Grow Increasingly Relevant in Oncology Practice – OncLive

CONTEXT: Oncology news article on use of RWR in oncology. Nothing new in terms of data use, more confirmation of RWD in oncology research. However, an interesting perspective from the Continue Reading

Posted On : February 24, 2021 Published By : stuart.mccully
Category:
  • Recently Released
  • RWR & COVID 19

Israel’s Data and Determining Impact of Pfizer Vaccine

IMPACT: The power of numbers…real-world data from 3.5 million vaccinated Israeli’s shows impact/ effectiveness of the Pfizer vaccine during early phase of roll out. READ TIME: 2 min *1. “Among Continue Reading

Posted On : February 16, 2021 Published By : Mark Lorkowski
Category:
  • Health Tech
  • Medical Devices
  • Recently Released

“InSilicoTrials: accelerating the uptake of simulation in clinical research – Medical Device Network”

CONTEXT: European initiative to explore “In-Silico” research. Not so much “Real World” as “Brave New World” utilising computer models to test safety and efficacy of medical devices. Hopefully this isn’t Continue Reading

Posted On : February 16, 2021 Published By : Mark Lorkowski
Category:
  • Real World Research (RWR)
  • Recently Released

Real World Research example in rare disease use case

CONTEXT: Real world research showing value in rare disease research where RCTs cannot generate the statistical power traditionally needed with so few available patients. New methods to interpret the RWD Continue Reading

Posted On : February 16, 2021 Published By : Mark Lorkowski
Category:
  • Recently Released
  • RWE - Real World Evidence

ADA: Sanofi bolsters Soliqua with real-world data showing starting insulin, GLP-1 together helps control blood sugar – FiercePharma

IMPACT: Taking insulin and a GLP-1 agonist significantly increases the ability of achievement stable blood sugar levels READ TIME: 2 mins * 1. “Sanofi’s Soliqua combines an insulin with a Continue Reading

Posted On : February 8, 2021 Published By : Mark Lorkowski
Data sharing
Category:
  • Real World Research (RWR)
  • Recently Released

Human experimentation oversight committee wants to approve Israel-Pfizer data-sharing deal – CTech

Quick Notes: CONTEXT:  RWD, RWE, Pfizer, Isaeli Government, Data Transparency, Real-World Epidemiological Evidence Collaboration Agreement IMPACT:  Sharing of Real-World Epidemiological Evidence to improve understanding of impact of COVID-19 vaccination Time Continue Reading

Posted On : January 29, 2021 Published By : stuart.mccully
Category:
  • Medical Devices
  • Recently Released
  • Regulatory
  • RWE
  • RWR & Regulators

Medical Device Innovation Consortium Releases Real-World Evidence Framework for In Vitro Diagnostics – Business Wire

Quick Notes: CONTEXT:  USA, IVDs, RWE, Real-World Evidence Framework for regulatory decision-making for in vitro diagnostics (IVDs) IMPACT:  step forward in providing the valuable information that IVD manufacturers and others Continue Reading

Posted On : January 29, 2021 Published By : stuart.mccully

Posts navigation

Older posts

XKCD Mental Break

Coffee Break Cartoon XKCD

We don’t spam! Read more in our privacy policy

Check your inbox or spam folder to confirm your signup and download

Copyright RedBird 2021
Theme: Royal Magazine by ThemeinWP
  • Cookie Policy (EU)
  • Privacy Statement (EU)
  • Impressum
  • Cookie Policy (UK)
  • Privacy Statement (UK)
  • Cookie Policy (US)
  • Cookie Policy (CA)
  • Privacy Statement (CA)
  • Disclaimer
  • Privacy Statement (US)
Manage Cookie Consent
We use cookies to optimize our website and our service.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}